Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 317 - Sulfones; Sulfoxides
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
07/2003
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119885 1,2-Diaminocyclopentanes, e.g., N-(2-(3-(4-chlorophenyl)-propylamino)cyclopentyl)-2-(5-(3,4 -dimethoxyphenyl)pyrimidin-2-ylsulfanyl)acetamide; inhibit eosinphil recruitment; skindisorders; asthma; antiinflammatory agents, antiallergens
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119807 Inhibit Procollagen C-proteinase; antiscarring treatment for wounds.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1426390A Process for producing bis (4-hydroxy-3-nitrophenyl) compound
06/25/2003CN1426388A Process for preparation of 2-halobenzoic acids
06/25/2003CN1425650A Process for extracting alliin from fresh garlic
06/25/2003CN1112356C Nitromethylthiobenzene derivative as inhibitors of aldose reductase
06/24/2003US6583321 4′-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/24/2003US6583306 Forming dioxolane derivative of citramalic acid; replacing free carboxylic acid with leaving group; coupling with hydroxyl, amino, thiol, sulphinyl or sulphonyl reactive compound; deprotecting; amidation with aniline derivitive
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049666A2 Compounds for a controlled release of active molecules
06/19/2003US20030114710 Optical information recording medium and novel immonium compound
06/19/2003US20030114681 C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
06/19/2003US20030114538 Styryl sulfone anticancer agents
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114496 Treatment or prevention of Alzheimer's disease
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468231A1 Compounds for a controlled release of active molecules
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1098874B1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
06/18/2003EP0946492B1 Novel 2-fluoroacrylic acid derivatives, novel mixtures of herbicides and antidotes and the use thereof
06/18/2003CN1424938A High surface microporous active materials TIQ-6 and METIQ-6 in oxidation reactions
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6580006 Reacting tetrafluoroethylene and sulfuryl fluoride in presence of metal fluoride and crown ether
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003048108A2 Compounds for treatment of inflammation, diabetes and related disorders
06/12/2003WO2003047508A2 Paclitaxel solvates
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109750 Process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene-sulfonyl chlorides and their intermediates
06/12/2003US20030109715 3,4-Dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317425A2 Resorcinol derivatives
06/11/2003EP1228077B1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423632A Aromatic diamide derivatives or salts thereof, agricultural/norticultural chemicals and method of using the same
06/11/2003CN1423631A Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
06/10/2003US6576675 Such as 4-fluorostyryl-4-iodobenzylsulfone; targeting receptor tyrosine kinases
06/10/2003US6576596 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003WO2003045903A1 Hydroxyethylene compounds with asp2 inhibitory activity
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003US20030105363 To an aldehyde or ketone; regenerating and recycling the fluorous sulfoxide
06/05/2003US20030105331 Use as anorectics, treating obesity and type II diabetes; C2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group
06/05/2003US20030105145 Polysubstituted indan-1-ol compounds, and methods for their preparation and use
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105095 4'-Methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105078 Diphenyl derivatives
06/04/2003EP1315697A1 Herbicidal benzoyl cyclohexane dione
06/04/2003EP0980353B1 Cationically polymerizable compositions capable of being coated by electrostatic assistance
06/04/2003EP0973734B1 Crosslinkable bi-sulphonyl derivatives and their uses for preparing ion-exchanging membranes
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1110464C Process for producing bromine compound
06/03/2003US6573404 Intermediates in industrial organic synthesis, e.g. in the preparation of fine chemicals, dyes and crop-protection compositions
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003CA2115432C Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors
05/2003
05/30/2003WO2003043977A1 Process for preparation of geranyl aryl sulfones
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043624A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
05/30/2003WO2002094765A3 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
05/29/2003US20030100785 Process for preparing carotenoid polyene chain compounds and intermediates for preparing the same
05/29/2003US20030100583 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/28/2003EP1314724A1 Novel thermodynamically stable crystal modification of (2-(2-Chloro-4-mesyl-benzoyl)cyclohexane-1,3-dione)
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314712A1 Nf-kappa-b inhibitor containing substituted benzoic acid derivative as active ingredient
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003US20030096996 Process for producing organotitanium compound and process for addition reaction
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096856 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer
05/22/2003US20030096844 Cannabinoid receptor ligands
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 159